UniQure, Syndax, Erasca Drawing Fresh Analyst Interest
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Fund reallocation matters when priorities shift. This intro explains why adjusting allocations supports your financial plan.
21,833 articlesThree clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Miami's Dolphins stunned the league by agreeing to a record $99.2 million exit package for a veteran player. The move...
Saudi Aramco signals it could restore full output within days if Hormuz reopens, a development that investors are wat...
Trump acknowledges a philosophical difference with his VP on Iran, while markets react to the evolving policy landsca...
Oil prices cooled after news that wealthy nations may coordinate an emergency reserve release. Analysts warn that pri...
The February CPI data show inflation stayed above the FED's 2% goal even as monthly gains cooled, keeping markets foc...
February CPI data shows inflation holding at 2.4% year over year with core at 2.5%. Shelter, food, and transport tilt...
In 2026, AI budgets surge while pilots fade. A four‑pillar playbook separates winners from the rest, focusing on data...
Nvidia’s CEO Jensen Huang faces a modest cash bonus despite a multitrillion-dollar market cap, highlighting how execu...
Coinbase CEO Brian Armstrong refutes accusations of lobbying against a Bitcoin de minimis tax exemption as lawmakers ...
Palantir reports strong government revenue growth while warning that adversaries are increasingly targeting AI data c...
private listings escalating. here’s a timely look at how brokerages and portals could resolve mounting tensions while...